Bumrungrad Hospital Public Company Limited - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Bumrungrad Hospital Public Company Limited - Depositary Receipt (Common Stock)
US ˙ OTCPK ˙ TH0168010R13

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Bumrungrad Hospital Public Company Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 14,169 12,440 10,991 11,554 11,630 12,605 14,078 16,012 18,762 20,908 22,846 24,038 25,069 25,547 26,022 26,211 25,889 25,862 25,505 25,275
Change (%) -12.20 -11.65 5.13 0.65 8.38 11.69 13.73 17.17 11.44 9.27 5.22 4.29 1.91 1.86 0.73 -1.23 -0.10 -1.38 -0.90
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 8,512 7,677 7,128 7,391 7,347 7,731 8,377 9,111 10,227 11,099 11,855 12,257 12,699 12,895 12,891 12,858 12,576 12,503 12,397 12,252
Change (%) -9.81 -7.16 3.70 -0.60 5.23 8.35 8.77 12.24 8.53 6.81 3.39 3.60 1.54 -0.03 -0.26 -2.19 -0.58 -0.85 -1.17
% of Revenue 60.08 61.72 64.85 63.97 63.17 61.33 59.50 56.90 54.51 53.09 51.89 50.99 50.66 50.48 49.54 49.05 48.58 48.34 48.61 48.48
Gross Operating Profit 5,657 4,763 3,863 4,163 4,283 4,874 5,701 6,900 8,535 9,808 10,990 11,781 12,370 12,652 13,131 13,353 13,313 13,359 13,108 13,023
Change (%) -15.81 -18.88 7.76 2.89 13.78 16.99 21.03 23.68 14.92 12.05 7.20 5.00 2.28 3.79 1.69 -0.31 0.35 -1.88 -0.65
% of Revenue 39.92 38.28 35.15 36.03 36.83 38.66 40.50 43.10 45.49 46.91 48.11 49.01 49.34 49.52 50.46 50.95 51.42 51.66 51.39 51.52
SG&A 3,548 3,394 3,293 3,333 3,318 3,296 3,349 3,401 3,588 3,798 3,946 4,046 4,086 4,180 4,187 4,207 4,170 4,171 4,235 4,190
Change (%) -4.34 -2.98 1.21 -0.44 -0.67 1.61 1.56 5.48 5.86 3.90 2.52 1.00 2.30 0.16 0.48 -0.89 0.04 1.53 -1.07
% of Revenue 25.04 27.29 29.96 28.84 28.53 26.15 23.79 21.24 19.12 18.17 17.27 16.83 16.30 16.36 16.09 16.05 16.11 16.13 16.61 16.58
R&D
Change (%)
% of Revenue
OpEx 12,060 11,072 10,421 10,724 10,665 11,027 11,726 12,513 13,815 14,897 15,802 16,303 16,785 17,075 17,078 17,065 16,746 16,674 16,632 16,442
Change (%) -8.20 -5.88 2.91 -0.55 3.39 6.34 6.71 10.41 7.84 6.07 3.17 2.96 1.73 0.02 -0.08 -1.87 -0.43 -0.25 -1.14
% of Revenue 85.12 89.00 94.81 92.82 91.70 87.48 83.29 78.15 73.63 71.25 69.17 67.82 66.96 66.84 65.63 65.10 64.68 64.47 65.21 65.05
Operating Income 2,109 1,368 570 830 965 1,578 2,352 3,499 4,947 6,010 7,044 7,736 8,284 8,472 8,944 9,146 9,143 9,188 8,873 8,833
Change (%) -35.11 -58.33 45.58 16.25 63.48 49.10 48.76 41.38 21.49 17.20 9.82 7.09 2.27 5.58 2.26 -0.04 0.49 -3.43 -0.45
% of Revenue 14.88 11.00 5.19 7.18 8.30 12.52 16.71 21.85 26.37 28.75 30.83 32.18 33.04 33.16 34.37 34.90 35.32 35.53 34.79 34.95
Interest Expense -128 -128 -127 -126 -125 -120 -90 -60 -29 -4 -2 -2 -2 -2 -4 -6 -7 -8 -8 -8
Change (%) -0.31 -0.60 -0.88 -0.49 -4.29 -24.57 -33.76 -51.32 -87.82 -30.42 -11.63 -15.09 29.26 67.85 39.40 32.05 12.70 -1.01 2.05
% of Revenue -0.90 -1.03 -1.15 -1.09 -1.08 -0.95 -0.64 -0.37 -0.16 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.03 -0.03 -0.03 -0.03
Net Income 1,917 1,204 530 702 777 1,216 1,850 2,799 4,004 4,938 5,797 6,378 6,832 7,006 7,408 7,592 7,593 7,775 7,524 7,450
Change (%) -37.19 -55.98 32.46 10.61 56.55 52.14 51.34 43.06 23.32 17.38 10.04 7.10 2.56 5.73 2.48 0.01 2.40 -3.23 -0.99
% of Revenue 13.53 9.68 4.82 6.08 6.68 9.64 13.14 17.48 21.34 23.62 25.37 26.53 27.25 27.43 28.47 28.96 29.33 30.06 29.50 29.47

Source: Capital IQ

Other Listings
TH:BH-R
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista